- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00382018
S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo
A Randomized Phase III Trial to Test the Strategy of Changing Therapy Versus Maintaining Therapy for Metastatic Breast Cancer Patients Who Have Elevated Circulating Tumor Cell Levels at First Follow-Up Assessment
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Measuring blood levels of tumor cells may help in learning how well chemotherapy works to kill metastatic breast cancer cells and allow doctors to plan better treatment. When blood levels of tumor cells are high while receiving chemotherapy, it is not yet known whether it is more effective to change chemotherapy regimens at that time or wait until disease progression.
PURPOSE: This randomized phase III trial is studying treatment decision making based on blood levels of tumor cells in women with metastatic breast cancer receiving chemotherapy.
Study Overview
Detailed Description
OBJECTIVES:
Primary
- Determine whether women with metastatic breast cancer and elevated circulating tumor cells (CTCs) (≥ 5 per 7.5 mL of whole blood) after 3 weeks of first-line chemotherapy derive increased overall survival from changing to an alternative chemotherapy regimen at the next course rather than waiting for clinical evidence of progressive disease before changing to an alternative chemotherapy regimen.
- Determine whether these patients derive increased progression-free survival (PFS) from changing to an alternative chemotherapy regimen at the next course rather than waiting for clinical evidence of progressive disease before changing to an alternative chemotherapy regimen.
- Confirm previous findings that patients with < 5 CTCs per 7.5 mL of whole blood on initial screening have longer median OS and PFS than patients with ≥ 5 CTCs per 7.5 mL of whole blood.
- Determine the prognostic value of sequentially collected CTC values in these patients.
- Compare toxicity between patients with and without elevated CTCs after 3 weeks of first-line chemotherapy AND between the two randomized treatment arms.
Secondary
- Compare the prognostic and predictive value of CTC number vs breast cancer tumor markers, including CA 15-3 and carcinoembryonic antigen.
- Create a serum specimen bank for future biologic investigation.
OUTLINE: This is a partially blinded, partially randomized, multicenter study. Patients are assigned to 1 of 3 groups based on circulating tumor cells (CTCs) after 1 course of chemotherapy.
All patients undergo blood collection before their first dose of first-line chemotherapy* to determine baseline CTC count. Patients with < 5 CTCs at baseline are assigned to group I. Patients with ≥ 5 CTCs at baseline undergo a second blood draw on day 22 (after completion of 1 course of chemotherapy). Patients with < 5 CTCs after completing 1 course of chemotherapy are assigned to group 2. Patients with ≥ 5 CTCs after completion of 1 course of chemotherapy are assigned to group 3.
NOTE: *Chemotherapy may be initiated while waiting for the baseline CTC result.
- Group 1 (low risk of early progression): Patients continue to receive regular treatment without change at the discretion of the physician. Patients are eligible for other first-line chemotherapy trials. No further blood is collected.
- Group 2 (moderate risk of early progression): Patients continue to receive their current chemotherapy regimen without change.
Group 3 (high risk of early progression): Patients are stratified according to HER-2 status (positive vs negative) and disease type (bone-only vs measurable disease). Patients are randomized to 1 of 2 treatment arms.
- Arm I: Patients continue with their current chemotherapy regimen without change.
- Arm II: Patients switch to a different chemotherapy regimen. Selection of a new chemotherapy regimen is made by the patient's doctor.
Patients receiving hormonal therapy or biologic therapy and chemotherapy continue to receive the hormonal or biologic therapy unchanged regardless of CTC level.
In groups 2 and 3, blood is collected periodically during chemotherapy and then at the completion of chemotherapy. Samples are examined for CTCs via the CellSearch™ blood test. Blood is also tested for CA 15-3 and carcinoembryonic antigen (CEA).
After completion of study therapy, patients are followed for up to 5 years.
PROJECTED ACCRUAL: A total of 500 patients will be accrued for this study.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Alabama
-
Anniston, Alabama, United States, 36207
- Regional Medical Center
-
-
Alaska
-
Anchorage, Alaska, United States, 99508
- Providence Cancer Center
-
Anchorage, Alaska, United States, 99508
- Alaska Regional Hospital Cancer Center
-
-
Arkansas
-
Jonesboro, Arkansas, United States, 72401
- NEA Medical Center - Stadium Boulevard
-
-
California
-
Glendale, California, United States, 91204
- Glendale Memorial Hospital Comprehensive Cancer Center
-
Greenbrae, California, United States, 94904
- California Cancer Care, Incorporated - Greenbrae
-
Loma Linda, California, United States, 92354
- Loma Linda University Cancer Institute at Loma Linda University Medical Center
-
Los Angeles, California, United States, 90089-9181
- USC/Norris Comprehensive Cancer Center and Hospital
-
Mountain View, California, United States, 94040
- Camino Medical Group - Treatment Center
-
Palo Alto, California, United States, 94301
- Palo Alto Medical Foundation
-
Stanford, California, United States, 94305-5824
- Stanford Cancer Center
-
-
Colorado
-
Alamosa, Colorado, United States, 81101
- San Luis Valley Regional Medical Center
-
Aurora, Colorado, United States, 80045
- University of Colorado Cancer Center at UC Health Sciences Center
-
Denver, Colorado, United States, 80220
- Veterans Affairs Medical Center - Denver
-
Edwards, Colorado, United States, 81632
- Shaw Regional Cancer Center
-
Glenwood Springs, Colorado, United States, 81601
- Valley View Hospital Cancer Center
-
Grand Junction, Colorado, United States, 81502
- St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
-
Montrose, Colorado, United States, 81401
- Montrose Memorial Hospital Cancer Center
-
-
Connecticut
-
Hartford, Connecticut, United States, 06105
- Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
-
New Haven, Connecticut, United States, 06520-8028
- Yale Cancer Center
-
-
Florida
-
Orlando, Florida, United States, 32803-1273
- Florida Hospital Cancer Institute at Florida Hospital Orlando
-
-
Georgia
-
Valdosta, Georgia, United States, 31602
- Pearlman Comprehensive Cancer Center at South Georgia Medical Center
-
-
Hawaii
-
'Aiea, Hawaii, United States, 96701
- Kapiolani Medical Center at Pali Momi
-
Honolulu, Hawaii, United States, 96813
- Cancer Research Center of Hawaii
-
Honolulu, Hawaii, United States, 96826
- Kapiolani Medical Center for Women and Children
-
Honolulu, Hawaii, United States, 96813
- OnCare Hawaii, Incorporated - Lusitana
-
Honolulu, Hawaii, United States, 96813
- Queen's Cancer Institute at Queen's Medical Center
-
Honolulu, Hawaii, United States, 96813
- Straub Clinic and Hospital, Incorporated
-
Honolulu, Hawaii, United States, 96817
- Hawaii Medical Center - East
-
Honolulu, Hawaii, United States, 96817
- OnCare Hawaii, Incorporated - Kuakini
-
Honolulu, Hawaii, United States, 96859
- Tripler Army Medical Center
-
Wailuku, Hawaii, United States, 96793
- Maui Memorial Medical Center
-
Wailuku, Hawaii, United States, 96793
- Pacific Cancer Institute - Maui
-
-
Idaho
-
Boise, Idaho, United States, 83706
- Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
-
-
Illinois
-
Aurora, Illinois, United States, 60504
- Rush-Copley Cancer Care Center
-
Chicago, Illinois, United States, 60640
- Louis A. Weiss Memorial Hospital
-
Chicago, Illinois, United States, 60631
- Resurrection Medical Center
-
Elmhurst, Illinois, United States, 60126
- Elmhurst Memorial Hospital
-
Harvey, Illinois, United States, 60426
- Ingalls Cancer Care Center at Ingalls Memorial Hospital
-
Rockford, Illinois, United States, 61104-2315
- Swedish-American Regional Cancer Center
-
Urbana, Illinois, United States, 61801
- CCOP - Carle Cancer Center
-
-
Indiana
-
Elkhart, Indiana, United States, 46515
- Elkhart General Hospital
-
Elkhart, Indiana, United States, 46514-2098
- Elkhart Clinic, LLC
-
Elkhart, Indiana, United States, 46514
- Michiana Hematology-Oncology, PC - Elkhart
-
Indianapolis, Indiana, United States, 46260
- St. Vincent Indianapolis Hospital
-
Indianapolis, Indiana, United States, 46256
- Community Regional Cancer Care at Community Hospital North
-
Kokomo, Indiana, United States, 46904
- Howard Community Hospital
-
La Porte, Indiana, United States, 46350
- Center for Cancer Therapy at LaPorte Hospital and Health Services
-
Michigan City, Indiana, United States, 46360
- Saint Anthony Memorial Health Centers
-
Mishawaka, Indiana, United States, 46545-1470
- Michiana Hematology-Oncology, PC - South Bend
-
Mishawaka, Indiana, United States, 46545-1470
- Saint Joseph Regional Medical Center
-
Muncie, Indiana, United States, 47303-3499
- Cancer Center at Ball Memorial Hospital
-
Plymouth, Indiana, United States, 46563
- Michiana Hematology Oncology PC - Plymouth
-
South Bend, Indiana, United States, 46601
- Memorial Hospital of South Bend
-
South Bend, Indiana, United States, 46601
- CCOP - Northern Indiana CR Consortium
-
Westville, Indiana, United States, 46391
- Michiana Hematology Oncology PC - La Porte
-
-
Iowa
-
Ames, Iowa, United States, 50010
- McFarland Clinic, PC
-
Sioux City, Iowa, United States, 51101
- Siouxland Hematology-Oncology Associates, LLP
-
Sioux City, Iowa, United States, 51102
- Mercy Medical Center - Sioux City
-
Sioux City, Iowa, United States, 51104
- St. Luke's Regional Medical Center
-
Waterloo, Iowa, United States, 50702
- Covenant Cancer Treatment Center
-
-
Kansas
-
Salina, Kansas, United States, 67401
- Tammy Walker Cancer Center at Salina Regional Health Center
-
Topeka, Kansas, United States, 66606
- Cotton-O'Neil Cancer Center
-
-
Maine
-
Portland, Maine, United States, 04101
- Mercy Hospital
-
-
Maryland
-
Baltimore, Maryland, United States, 21215
- Alvin and Lois Lapidus Cancer Institute at Sinai Hospital
-
-
Massachusetts
-
Worcester, Massachusetts, United States, 01608
- Saint Vincent Hospital at Worcester Medical Center
-
-
Michigan
-
Adrian, Michigan, United States, 49221
- Hickman Cancer Center at Bixby Medical Center
-
Ann Arbor, Michigan, United States, 48109-0942
- University of Michigan Comprehensive Cancer Center
-
Ann Arbor, Michigan, United States, 48106-0995
- Saint Joseph Mercy Cancer Center
-
Ann Arbor, Michigan, United States, 48106
- CCOP - Michigan Cancer Research Consortium
-
Battle Creek, Michigan, United States, 49017
- Battle Creek Health System Cancer Care Center
-
Bay City, Michigan, United States, 48708
- Bay Regional Medical Center
-
Big Rapids, Michigan, United States, 49307
- Mecosta County Medical Center
-
Dearborn, Michigan, United States, 48123-2500
- Oakwood Cancer Center at Oakwood Hospital and Medical Center
-
Detroit, Michigan, United States, 48202
- Josephine Ford Cancer Center at Henry Ford Hospital
-
Detroit, Michigan, United States, 48201-1379
- Barbara Ann Karmanos Cancer Institute
-
Escanaba, Michigan, United States, 49431
- Green Bay Oncology, Limited - Escanaba
-
Flint, Michigan, United States, 48503
- Hurley Medical Center
-
Flint, Michigan, United States, 48503
- Genesys Hurley Cancer Institute
-
Grand Rapids, Michigan, United States, 49503
- Butterworth Hospital at Spectrum Health
-
Grand Rapids, Michigan, United States, 49503
- CCOP - Grand Rapids
-
Grand Rapids, Michigan, United States, 49503
- Lacks Cancer Center at Saint Mary's Health Care
-
Grosse Pointe Woods, Michigan, United States, 48236
- Van Elslander Cancer Center at St. John Hospital and Medical Center
-
Iron Mountain, Michigan, United States, 49801
- Dickinson County Healthcare System
-
Jackson, Michigan, United States, 49201
- Foote Memorial Hospital
-
Kalamazoo, Michigan, United States, 49007
- Bronson Methodist Hospital
-
Kalamazoo, Michigan, United States, 49001
- Borgess Medical Center
-
Kalamazoo, Michigan, United States, 49007-3731
- West Michigan Cancer Center
-
Lansing, Michigan, United States, 48912-1811
- Sparrow Regional Cancer Center
-
Lansing, Michigan, United States, 48910
- Breslin Cancer Center at Ingham Regional Medical Center
-
Livonia, Michigan, United States, 48154
- St. Mary Mercy Hospital
-
Monroe, Michigan, United States, 48162
- Community Cancer Center of Monroe
-
Monroe, Michigan, United States, 48162
- Mercy Memorial Hospital - Monroe
-
Mount Clemens, Michigan, United States, 48043
- Clemens Regional Medical Center
-
Muskegon, Michigan, United States, 49443
- Mercy General Health Partners
-
Pontiac, Michigan, United States, 48341-2985
- St. Joseph Mercy Oakland
-
Port Huron, Michigan, United States, 48060
- Mercy Regional Cancer Center at Mercy Hospital
-
Reed City, Michigan, United States, 49677
- Spectrum Health Reed City Hospital
-
Royal Oak, Michigan, United States, 48073
- William Beaumont Hospital - Royal Oak Campus
-
Saginaw, Michigan, United States, 48601
- Seton Cancer Institute at Saint Mary's - Saginaw
-
Saint Joseph, Michigan, United States, 49085
- Lakeside Cancer Specialists, PLLC
-
Saint Joseph, Michigan, United States, 49085
- Lakeland Regional Cancer Care Center - St. Joseph
-
Southfield, Michigan, United States, 48075
- Providence Cancer Institute at Providence Hospital - Southfield Campus
-
Traverse City, Michigan, United States, 49684
- Munson Medical Center
-
Warren, Michigan, United States, 48093
- St. John Macomb Hospital
-
-
Minnesota
-
Alexandria, Minnesota, United States, 56308
-
Burnsville, Minnesota, United States, 55337
- Fairview Ridges Hospital
-
Coon Rapids, Minnesota, United States, 55433
- Mercy and Unity Cancer Center at Mercy Hospital
-
Edina, Minnesota, United States, 55435
- Fairview Southdale Hospital
-
Fridley, Minnesota, United States, 55432
- Mercy and Unity Cancer Center at Unity Hospital
-
Hutchinson, Minnesota, United States, 55350
- Hutchinson Area Health Care
-
Maplewood, Minnesota, United States, 55109
- Minnesota Oncology Hematology, PA - Maplewood
-
Maplewood, Minnesota, United States, 55109
- HealthEast Cancer Care at St. John's Hospital
-
Minneapolis, Minnesota, United States, 55407
- Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
-
Minneapolis, Minnesota, United States, 55415
- Hennepin County Medical Center - Minneapolis
-
Robbinsdale, Minnesota, United States, 55422-2900
- Humphrey Cancer Center at North Memorial Outpatient Center
-
Saint Cloud, Minnesota, United States, 56303
- CentraCare Clinic - River Campus
-
Saint Cloud, Minnesota, United States, 56303
- Coborn Cancer Center
-
Saint Louis Park, Minnesota, United States, 55416
- CCOP - Metro-Minnesota
-
Saint Louis Park, Minnesota, United States, 55416
- Park Nicollet Cancer Center
-
Saint Paul, Minnesota, United States, 55102
- United Hospital
-
Saint Paul, Minnesota, United States, 55101
- Regions Hospital Cancer Care Center
-
Shakopee, Minnesota, United States, 55379
- St. Francis Cancer Center at St. Francis Medical Center
-
Stillwater, Minnesota, United States, 55082
- Lakeview Hospital
-
Waconia, Minnesota, United States, 55387
- Ridgeview Medical Center
-
Willmar, Minnesota, United States, 56201
- Willmar Cancer Center at Rice Memorial Hospital
-
Woodbury, Minnesota, United States, 55125
- Minnesota Oncology Hematology, PA - Woodbury
-
-
Mississippi
-
Jackson, Mississippi, United States, 39216
- University of Mississippi Cancer Clinic
-
Pascagoula, Mississippi, United States, 39581
- Regional Cancer Center at Singing River Hospital
-
-
Missouri
-
Bolivar, Missouri, United States, 65613
- Central Care Cancer Center at Carrie J. Babb Cancer Center
-
Cape Girardeau, Missouri, United States, 63703
- Southeast Cancer Center
-
Jefferson City, Missouri, United States, 65109
- Goldschmidt Cancer Center
-
Saint Louis, Missouri, United States, 63131
- Missouri Baptist Cancer Center
-
Saint Louis, Missouri, United States, 63141
- Comprehensive Cancer Care, PC
-
Springfield, Missouri, United States, 65802
- CCOP - Cancer Research for the Ozarks
-
Springfield, Missouri, United States, 65804
- St. John's Regional Health Center
-
Springfield, Missouri, United States, 65807
- Hulston Cancer Center at Cox Medical Center South
-
-
Montana
-
Billings, Montana, United States, 59101
- CCOP - Montana Cancer Consortium
-
Billings, Montana, United States, 59101
- St. Vincent Healthcare Cancer Care Services
-
Billings, Montana, United States, 59107-7000
- Billings Clinic - Downtown
-
Billings, Montana, United States, 59102
- Hematology-Oncology Centers of the Northern Rockies - Billings
-
Bozeman, Montana, United States, 59715
- Bozeman Deaconess Cancer Center
-
Butte, Montana, United States, 59701
- St. James Healthcare Cancer Care
-
Great Falls, Montana, United States, 59405
- Great Falls Clinic - Main Facility
-
Great Falls, Montana, United States, 59405-5309
- Big Sky Oncology
-
Great Falls, Montana, United States, 59405
- Sletten Cancer Institute at Benefis Healthcare
-
Havre, Montana, United States, 59501
- Northern Montana Hospital
-
Helena, Montana, United States, 59601
- St. Peter's Hospital
-
Kalispell, Montana, United States, 59901
- Kalispell Regional Medical Center
-
Kalispell, Montana, United States, 59901
- Glacier Oncology, PLLC
-
Kalispell, Montana, United States, 59901
- Kalispell Medical Oncology at KRMC
-
Missoula, Montana, United States, 59807-7877
- Montana Cancer Specialists at Montana Cancer Center
-
Missoula, Montana, United States, 59807
- Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
-
-
Nebraska
-
Kearney, Nebraska, United States, 68848-1990
- Good Samaritan Cancer Center at Good Samaritan Hospital
-
-
New Hampshire
-
Lebanon, New Hampshire, United States, 03756-0002
- Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
-
-
New Jersey
-
New Brunswick, New Jersey, United States, 08901
- Saint Peter's University Hospital
-
Newark, New Jersey, United States, 07112
- Newark Beth Israel Medical Center
-
Newark, New Jersey, United States, 07103
- UMDNJ University Hospital
-
Paterson, New Jersey, United States, 07503
- St. Joseph's Hospital and Medical Center
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87131-5636
- University of New Mexico Cancer Center
-
Albuquerque, New Mexico, United States, 87106
- Hematology Oncology Associates, PC
-
Albuquerque, New Mexico, United States, 87102
- Lovelace Medical Center - Downtown
-
Albuquerque, New Mexico, United States, 87110
- Presbyterian Cancer Treatment Center at Presbyterian Kaseman Hospital
-
Las Cruces, New Mexico, United States, 88011
- University of New Mexico Cancer Center - South
-
-
New York
-
Buffalo, New York, United States, 14263-0001
- Roswell Park Cancer Institute
-
East Syracuse, New York, United States, 13057
- CCOP - Hematology-Oncology Associates of Central New York
-
The Bronx, New York, United States, 10461
- Albert Einstein Cancer Center at Albert Einstein College of Medicine
-
Utica, New York, United States, 13502
- Faxton Regional Cancer Center
-
White Plains, New York, United States, 10601
- Dickstein Cancer Treatment Center at White Plains Hospital Center
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke Cancer Institute
-
Goldsboro, North Carolina, United States, 27534
- Wayne Memorial Hospital, Incorporated
-
Hendersonville, North Carolina, United States, 28791
- Pardee Memorial Hospital
-
Kinston, North Carolina, United States, 28501
- Kinston Medical Specialists
-
Lumberton, North Carolina, United States, 28359
- Southeastern Regional Medical Center
-
Oxford, North Carolina, United States, 27565
- Granville Medical Center
-
Raleigh, North Carolina, United States, 27609
- Duke Health Raleigh Hospital
-
Roxboro, North Carolina, United States, 27573
- Person Memorial Hospital
-
-
North Dakota
-
Bismarck, North Dakota, United States, 58501
- Bismarck Cancer Center
-
Bismarck, North Dakota, United States, 58501
- Medcenter One Hospital Cancer Care Center
-
Bismarck, North Dakota, United States, 58501
- Mid Dakota Clinic, PC
-
Bismarck, North Dakota, United States, 58502
- St. Alexius Medical Center Cancer Center
-
Grand Forks, North Dakota, United States, 58201
- Altru Cancer Center at Altru Hospital
-
-
Ohio
-
Beachwood, Ohio, United States, 44122
- Cleveland Clinic Beachwood Family Health and Surgery Center
-
Bowling Green, Ohio, United States, 43402
- Wood County Oncology Center
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic Taussig Cancer Center
-
Cleveland, Ohio, United States, 44111
- Cleveland Clinic Cancer Center at Fairview Hospital
-
Elyria, Ohio, United States, 44035
- Community Cancer Center
-
Elyria, Ohio, United States, 44035
- Hematology Oncology Center
-
Independence, Ohio, United States, 44131
- Cleveland Clinic Cancer Center
-
Lima, Ohio, United States, 45804
- Lima Memorial Hospital
-
Lima, Ohio, United States, 45801
- St. Rita's Medical Center
-
Maumee, Ohio, United States, 43537-1839
- Northwest Ohio Oncology Center
-
Mayfield Heights, Ohio, United States, 44124
- Hillcrest Cancer Center at Hillcrest Hospital
-
Norwalk, Ohio, United States, 44857
- Fisher-Titus Medical Center
-
Oregon, Ohio, United States, 43616
- St. Charles Mercy Hospital
-
Oregon, Ohio, United States, 43616
- Toledo Clinic - Oregon
-
Parma, Ohio, United States, 44129
- Parma Community General Hospital
-
Sandusky, Ohio, United States, 44870
- North Coast Cancer Care, Incorporated
-
Strongsville, Ohio, United States, 44136
- Cleveland Clinic Foundation - Strongsville
-
Sylvania, Ohio, United States, 43560
- Flower Hospital Cancer Center
-
Tiffin, Ohio, United States, 44883
- Mercy Hospital of Tiffin
-
Toledo, Ohio, United States, 43608
- St. Vincent Mercy Medical Center
-
Toledo, Ohio, United States, 43606
- Toledo Hospital
-
Toledo, Ohio, United States, 43614
- Medical University of Ohio Cancer Center
-
Toledo, Ohio, United States, 43617
- CCOP - Toledo Community Hospital
-
Toledo, Ohio, United States, 43623
- Toledo Clinic, Incorporated - Main Clinic
-
Toledo, Ohio, United States, 43623
- St. Anne Mercy Hospital
-
Wauseon, Ohio, United States, 43567
- Fulton County Health Center
-
Wooster, Ohio, United States, 44691
- Cleveland Clinic - Wooster
-
-
Oklahoma
-
Tulsa, Oklahoma, United States, 74136
- Natalie Warren Bryant Cancer Center at St. Francis Hospital
-
-
Oregon
-
Bend, Oregon, United States, 97701
- St. Charles Medical Center - Bend
-
Clackamas, Oregon, United States, 97015
- Clackamas Radiation Oncology Center
-
Coos Bay, Oregon, United States, 97420
- Bay Area Hospital
-
Grants Pass, Oregon, United States, 97527
- Three Rivers Community Hospital
-
Medford, Oregon, United States, 97504
- Dubs Cancer Center at Rogue Valley Medical Center
-
Medford, Oregon, United States, 97504
- Providence Cancer Center at PMCC
-
Milwaukie, Oregon, United States, 97222
- Providence Milwaukie Hospital
-
Newberg, Oregon, United States, 97132
- Providence Newberg Medical Center
-
Oregon City, Oregon, United States, 97045
- Willamette Falls Hospital
-
Portland, Oregon, United States, 97213-2967
- Providence Cancer Center at Providence Portland Medical Center
-
Portland, Oregon, United States, 97225
- CCOP - Columbia River Oncology Program
-
Portland, Oregon, United States, 97225
- Providence St. Vincent Medical Center
-
-
Pennsylvania
-
Ephrata, Pennsylvania, United States, 17522
- Ephrata Cancer Center at Ephrata Community Hospital
-
Philadelphia, Pennsylvania, United States, 19111-2497
- Fox Chase Cancer Center - Philadelphia
-
Phoenixville, Pennsylvania, United States, 19460
- Cancer Center at Phoenixville Hospital
-
Pittsburgh, Pennsylvania, United States, 15232
- UPMC Cancer Centers
-
Reading, Pennsylvania, United States, 19612-6052
- McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
-
Sayre, Pennsylvania, United States, 18840
- Guthrie Cancer Center at Guthrie Clinic Sayre
-
Scranton, Pennsylvania, United States, 18508
- Hematology and Oncology Associates of Northeastern Pennsylvania
-
-
South Carolina
-
Charleston, South Carolina, United States, 29401
- Roper St. Francis Cancer Center at Roper Hospital
-
Easley, South Carolina, United States, 29640
- Cancer Centers of the Carolinas - Easley
-
Greenville, South Carolina, United States, 29615
- CCOP - Greenville
-
Greenville, South Carolina, United States, 29605
- Greenville Hospital Cancer Center
-
Greenville, South Carolina, United States, 29605
- Cancer Centers of the Carolinas - Faris Road
-
Greenville, South Carolina, United States, 29605
- Cancer Centers of the Carolinas - Grove Commons
-
Greer, South Carolina, United States, 29650
- Cancer Centers of the Carolinas - Greer Medical Oncology
-
Seneca, South Carolina, United States, 29672
- Cancer Centers of the Carolinas - Seneca
-
Spartanburg, South Carolina, United States, 29307
- Cancer Centers of the Carolinas - Spartanburg
-
-
Tennessee
-
Jackson, Tennessee, United States, 38301
- West Tennessee Cancer Center at Jackson-Madison County General Hospital
-
-
Texas
-
Houston, Texas, United States, 77030-4009
- M. D. Anderson Cancer Center at University of Texas
-
San Antonio, Texas, United States, 78229
- Cancer Therapy and Research Center
-
San Antonio, Texas, United States, 78209
- Veterans Affairs Medical Center - San Antonio (Murphy)
-
San Antonio, Texas, United States, 78229-3900
- University of Texas Health Science Center at San Antonio
-
San Antonio, Texas, United States, 78229
- University Hospital - San Antonio
-
Temple, Texas, United States, 76508
- CCOP - Scott and White Hospital
-
-
Utah
-
American Fork, Utah, United States, 84003
- American Fork Hospital
-
Cedar City, Utah, United States, 84720
- Sandra L. Maxwell Cancer Center
-
Logan, Utah, United States, 84321
- Logan Regional Hospital
-
Murray, Utah, United States, 84157
- Jon and Karen Huntsman Cancer Center at Intermountain Medical Center
-
Ogden, Utah, United States, 84403
- Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
-
Provo, Utah, United States, 84604
- Utah Valley Regional Medical Center - Provo
-
Saint George, Utah, United States, 84770
- Dixie Regional Medical Center - East Campus
-
Salt Lake City, Utah, United States, 84143
- LDS Hospital
-
Salt Lake City, Utah, United States, 84106
- Utah Cancer Specialists at UCS Cancer Center
-
-
Virginia
-
Danville, Virginia, United States, 24541
- Danville Regional Medical Center
-
Fredericksburg, Virginia, United States, 22401
- Fredericksburg Oncology, Incorporated
-
Richmond, Virginia, United States, 23230
- Virginia Cancer Institute - West End
-
-
Washington
-
Anacortes, Washington, United States, 98221
- Island Hospital Cancer Care Center at Island Hospital
-
Bellingham, Washington, United States, 98225
- St. Joseph Cancer Center
-
Bremerton, Washington, United States, 98310
- Olympic Hematology and Oncology
-
Burien, Washington, United States, 98166
- Highline Medical Center Cancer Center
-
Centralia, Washington, United States, 98531-9027
- Providence Centralia Hospital
-
Federal Way, Washington, United States, 98003
- St. Francis Hospital
-
Kennewick, Washington, United States, 99336
- Columbia Basin Hematology
-
Mount Vernon, Washington, United States, 98274
- Skagit Valley Hospital Cancer Care Center
-
Olympia, Washington, United States, 98506-5166
- Providence St. Peter Hospital Regional Cancer Center
-
Poulsbo, Washington, United States, 98370
- Harrison Poulsbo Hematology and Onocology
-
Puyallup, Washington, United States, 98372
- Good Samaritan Cancer Center
-
Seattle, Washington, United States, 98109
- Fred Hutchinson Cancer Research Center
-
Seattle, Washington, United States, 98104
- Harborview Medical Center
-
Seattle, Washington, United States, 98104
- Minor and James Medical, PLLC
-
Seattle, Washington, United States, 98112
- Group Health Central Hospital
-
Seattle, Washington, United States, 98122-4307
- Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
-
Seattle, Washington, United States, 98195
- University Cancer Center at University of Washington Medical Center
-
Sedro-Woolley, Washington, United States, 98284
- North Puget Oncology at United General Hospital
-
Spokane, Washington, United States, 99202
- Cancer Care Northwest - Spokane South
-
Spokane, Washington, United States, 99218
- Evergreen Hematology and Oncology, PS
-
Tacoma, Washington, United States, 98405-3004
- Franciscan Cancer Center at St. Joseph Medical Center
-
Tacoma, Washington, United States, 98405
- Allenmore Hospital
-
Tacoma, Washington, United States, 98405
- CCOP - Northwest
-
Tacoma, Washington, United States, 98405
- MultiCare Regional Cancer Center at Tacoma General Hospital
-
Tacoma, Washington, United States, 98499
- St. Clare Hospital
-
Vancouver, Washington, United States, 98664
- Southwest Washington Medical Center Cancer Center
-
Wenatchee, Washington, United States, 98801-2028
- Wenatchee Valley Medical Center
-
-
Wisconsin
-
Green Bay, Wisconsin, United States, 54307-3508
- St. Vincent Hospital Regional Cancer Center
-
Green Bay, Wisconsin, United States, 54301-3526
- Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center
-
Green Bay, Wisconsin, United States, 54303
- Green Bay Oncology, Limited at St. Mary's Hospital
-
Green Bay, Wisconsin, United States, 54303
- St. Mary's Hospital Medical Center - Green Bay
-
La Crosse, Wisconsin, United States, 54601
- Gundersen Lutheran Center for Cancer and Blood
-
Manitowoc, Wisconsin, United States, 54221-1450
- Holy Family Memorial Medical Center Cancer Care Center
-
Marinette, Wisconsin, United States, 54143
- Bay Area Cancer Care Center at Bay Area Medical Center
-
Oconto Falls, Wisconsin, United States, 54154
- Green Bay Oncology, Limited - Oconto Falls
-
Sheboygan, Wisconsin, United States, 53081
- St. Nicholas Hospital
-
Sturgeon Bay, Wisconsin, United States, 54235
- Green Bay Oncology, Limited - Sturgeon Bay
-
Wauwatosa, Wisconsin, United States, 53226
- Oncology Alliance, SC - Milwaukee - West
-
-
Wyoming
-
Sheridan, Wyoming, United States, 82801
- Welch Cancer Center at Sheridan Memorial Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
DISEASE CHARACTERISTICS:
Histologically confirmed breast cancer
- Clinical evidence of metastatic disease (stage IV disease)
- Newly metastatic disease OR progressive metastatic disease while on hormonal therapy
Meets 1 of the following criteria:
- Measurable disease
- Bone-only disease* NOTE: *Patients with nonmeasurable disease that does not include bone are not eligible
HER-2 status determined by immunohistochemistry (IHC) or fluorescent in situ hybridization (FISH) assay
- HER-2 positivity is defined as IHC 3+ or FISH+
- If IHC is indeterminate (2+), FISH must be performed to classify disease
- Planning to undergo first-line chemotherapy for metastatic disease
- Patients with brain metastases must have stable disease for > 90 days after completion of prior radiotherapy to the brain
- No leptomeningeal disease
- Hormone receptor status not specified
PATIENT CHARACTERISTICS:
- Female
- Menopausal status not specified
- Zubrod performance status 0-2
- Not pregnant or nursing
- Negative pregnancy test
- No other malignancy within the past 5 years except adequately treated basal cell or squamous cell skin cancer or stage I or II cancer currently in complete remission
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Prior hormonal therapy, bisphosphonate therapy, trastuzumab (Herceptin®), and/or bevacizumab for metastatic disease allowed
- Any number of exogenous hormonal therapies for metastatic disease and/or as adjuvant therapy allowed
- At least 1 year since prior adjuvant chemotherapy
- At least 2 weeks since prior minor surgery and recovered
- At least 4 weeks since prior major surgery and recovered
- No prior chemotherapy for metastatic disease
- Concurrent hormonal therapy and/or bisphosphonate therapy allowed
- Concurrent trastuzumab and/or bevacizumab allowed
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Group 1
Patients continue to receive regular treatment without change at the discretion of the physician.
Patients are eligible for other first-line chemotherapy trials.
No further blood is collected.
|
No administration details available
|
Experimental: Group 2
Patients continue to receive their current chemotherapy regimen without change.
|
No administration details available
|
Active Comparator: Group 3, Arm I
Patients continue with their current chemotherapy regimen without change.
|
No administration details available
|
Experimental: Group 3, Arm II
Patients switch to a different chemotherapy regimen.
Selection of a new chemotherapy regimen is made by the patient's doctor.
|
No administration details available
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Overall Survival
Time Frame: Every 3 months until progression then every 6 months for 5 years or until death
|
From date of registration to date of death due to any cause.
Patients last known to be alive are censored at date of last contact.
|
Every 3 months until progression then every 6 months for 5 years or until death
|
Progression-free Survival
Time Frame: every 3 months until progression. From date of registration to date of first documentation of progressive disease, death due to any cause or symptomatic deterioration, whichever occurs first, assessed up to five years.
|
Progression is defined using Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.0), as a 20% increase in the sum of the longest diameter of target lesions, or a measurable increase in a non-target lesion, or the appearance of new lesions
|
every 3 months until progression. From date of registration to date of first documentation of progressive disease, death due to any cause or symptomatic deterioration, whichever occurs first, assessed up to five years.
|
Progression Free Survival
Time Frame: every 3 months until progression
|
From date of registration to date of first documentation of progressive disease, death due to any cause or symptomatic deterioration, whichever occurs first.
Patients last known to be alive and progression-free are censored at date of last contact.
|
every 3 months until progression
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Patients With Adverse Events That Are Related to Study Drugs
Time Frame: Toxicity assessment was evaluated after 3 weeks, 6 weeks, and every 6 weeks thereafter until progression
|
Adverse Events (AEs) are reported by CTCAE Version 3.0.
Only adverse events that are possibly, probably or definitely related to study drug are reported.
|
Toxicity assessment was evaluated after 3 weeks, 6 weeks, and every 6 weeks thereafter until progression
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Correlation of CTC Levels With Breast Cancer Tumor Markers
Time Frame: Baseline, Weeks 4, 8, 13, 25, 37 and at progression
|
Baseline, Weeks 4, 8, 13, 25, 37 and at progression
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Jeffrey B. Smerage, MD, PhD, University of Michigan Rogel Cancer Center
- Study Chair: Eric P. Winer, MD, Dana-Farber Cancer Institute
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CDR0000504319
- U10CA032102 (U.S. NIH Grant/Contract)
- S0500 (Other Identifier: SWOG)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of WashingtonTerminatedBreast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Stage IIB | Breast Cancer Stage IIA | Breast Cancer Stage IIIA | Breast Cancer Stage IIIB | Breast Cancer Stage IIIcUnited States
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast...United States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
Clinical Trials on chemotherapy
-
University of WashingtonNational Cancer Institute (NCI)CompletedAdult Acute Myeloid Leukemia | Adult Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingColorectal Adenocarcinoma | Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Colorectal Carcinoma Metastatic in the LungUnited States, Canada
-
Cancer Institute and Hospital, Chinese Academy...Unknown
-
International Atomic Energy AgencyCompletedNon Small Cell Lung CancerChile, China, Croatia, Egypt, India, Malaysia, Malta, Morocco, Pakistan, Panama, Peru, South Africa, Tunisia
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Ping LiangNot yet recruitingChemotherapy | Liver Metastases | Colorectal Carcinoma
-
Second Affiliated Hospital, School of Medicine,...UnknownUnresectable Gastric Cancer | Successful Conversion Rate of OperationChina
-
Yantai Yuhuangding HospitalRecruiting
-
Shenzhen SiBiono GeneTech Co.,LtdUnknown
-
Ruijin HospitalNot yet recruitingGastric Cancer | Neoadjuvant ChemotherapyChina